Nindanib 150mg Tablet Description:
Nindanib 150mg Tablet is a prescription medication that contains Nintedanib as its active ingredient. It is primarily used for the treatment of idiopathic pulmonary fibrosis (IPF), a chronic lung disease that causes scarring of lung tissue and leads to breathing difficulties. Nindanib works by inhibiting certain enzymes that are involved in the process of fibrosis, which helps to slow down the progression of IPF. Here is some important information about Nindanib 150mg Tablet:
Uses Of Nindanib 150mg Tablet:
Treatment of idiopathic pulmonary fibrosis (IPF)
Dosage Of Nindanib 150mg Tablet:
- The usual recommended dosage of Nindanib 150mg Tablet is one tablet taken orally twice daily, with food.
- The dosage may vary depending on the severity of the condition and the response to treatment. Always follow the dosage instructions provided by your healthcare provider.
- Store Nindanib 150mg Tablet at room temperature (25°C) in a tightly closed container, away from moisture and heat.
- Keep it out of reach of children and pets.
Side Effects Of Nindanib 150mg Tablet:
- Like all medications, Nindanib 150mg Tablet may cause some side effects. Common side effects may include diarrhea, nausea, vomiting, abdominal pain, decreased appetite, weight loss, fatigue, and elevated liver enzymes.
- Contact your healthcare provider if you experience any severe or persistent side effects.
- Inform your healthcare provider about any existing medical conditions or allergies you may have before starting Nindanib 150mg Tablet.
- Inform your healthcare provider about all the medications, herbal supplements, and vitamins you are currently taking to avoid any potential interactions.
- Nindanib may cause liver toxicity, so regular liver function tests may be required during treatment.
- It is not recommended for use in pregnant or breastfeeding women, as its safety during pregnancy and lactation has not been established.
- Nindanib is a prescription medication and should be used only under the guidance of a qualified healthcare provider.
- Do not exceed the recommended dosage or duration of treatment without consulting your healthcare provider.
- If you miss a dose of Nindanib 150mg Tablet, take it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and continue with your regular dosing schedule.
- Nindanib may interact with other medications, herbal supplements, or vitamins, potentially leading to adverse effects or reducing the effectiveness of the medication.
- Inform your healthcare provider about all the medications you are currently taking to avoid any potential interactions.
How long does it take for Nindanib 150mg Tablet to show its effect?
The response to Nindanib may vary depending on the individual and the severity of the condition. It may take several weeks or even months to see the full benefits of the medication. Follow your healthcare provider’s instructions and be patient.
Can Nindanib 150mg Tablet be used during pregnancy or while breastfeeding?
Nindanib is not recommended for use in pregnant or breastfeeding women, as its safety during pregnancy and lactation has not been established. Consult your healthcare provider for suitable alternatives if you are pregnant or breastfeeding.
- Nindanib 150mg Tablet is a prescription medication and should be used only as directed by a qualified healthcare provider.
- It is important to continue taking Nindanib 150mg Tablet regularly and as prescribed, even if you feel better, in order to effectively manage idiopathic pulmonary fibrosis (IPF).
- Nindanib may not be suitable for everyone, and its use should be based on individual patient characteristics, including age, overall health, and presence of other medical conditions. Your healthcare provider will determine the appropriate treatment plan for you.
- Nindanib is not approved for use in children and adolescents below 18 years of age.
- If you experience any severe side effects or have concerns about Nindanib 150mg Tablet, do not hesitate to contact your healthcare provider for further evaluation and management.